Literature DB >> 18513492

ING2 recruits histone methyltransferase activity with methylation site specificity distinct from histone H3 lysines 4 and 9.

Frauke Goeman1, Katja Otto, Sergiy Kyrylenko, Oliver Schmidt, Aria Baniahmad.   

Abstract

p33ING2 belongs to the ING-gene family that is involved in tumor suppression, DNA repair, cell cycle regulation, and cellular senescence. Most functions are dependent on the tumor suppressor p53. p33ING2 was also shown to bind to trimethylated lysine 4 of histone H3. Here, we show that p33ING2 contains a transferable silencing function, which is independent of p53. p33ING2-mediated gene silencing is resistant to the HDAC-inhibitor trichostatin A indicating that p33ING2 uses a non-HDAC class I or II pathway for gene repression in reporter assays. In line with that we show that p33ING2 is associated with histone methyltransferase (HMT) activity in vitro and in vivo, methylating specifically histone H3. Interestingly, the specificity is distinct from the MeCP2-recruited HMT. Mutation or methylation of lysine 9, a mark well known for repression, abrogates histone methylation by MeCP2 but not by the p33ING2 complex. Instead, the ING2-associated HMT shows an increased methylation activity if lysine 9 is methylated. In contrast, mutation or methylation of lysine 4, a methylation preferentially detected at active genes, led to a reduction of the ING2-associated HMT. Notably, also p33ING1 recruits HMT activity suggesting a more general biochemical interaction between members of p33ING family and HMT activity. Deletion analyses revealed that the ING2 C-terminus recruits HMT activity, which correlates with silencing function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513492     DOI: 10.1016/j.bbamcr.2008.04.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

2.  Trimethylation of histone H3 lysine 4 impairs methylation of histone H3 lysine 9: regulation of lysine methyltransferases by physical interaction with their substrates.

Authors:  Olivier Binda; Gary LeRoy; Dennis J Bua; Benjamin A Garcia; Or Gozani; Stéphane Richard
Journal:  Epigenetics       Date:  2010 Nov-Dec       Impact factor: 4.528

Review 3.  Inhibitor of Growth Factors Regulate Cellular Senescence.

Authors:  Soudeh Ghafouri-Fard; Mohammad Taheri; Aria Baniahmad
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

Review 4.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

5.  Knockdown of inhibitor of growth protein 2 inhibits cell invasion and enhances chemosensitivity to 5-FU in human gastric cancer cells.

Authors:  Juan Zhong; Lei Yang; Ning Liu; Jun Zheng; Cong-Yao Lin
Journal:  Dig Dis Sci       Date:  2013-07-18       Impact factor: 3.199

Review 6.  INGs are potential drug targets for cancer.

Authors:  Runyun Zhang; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

Review 7.  Reviewing the current classification of inhibitor of growth family proteins.

Authors:  Motoko Unoki; Kensuke Kumamoto; Seiichi Takenoshita; Curtis C Harris
Journal:  Cancer Sci       Date:  2009-04-28       Impact factor: 6.716

8.  The ING tumor suppressors in cellular senescence and chromatin.

Authors:  Susann Ludwig; Alexandra Klitzsch; Aria Baniahmad
Journal:  Cell Biosci       Date:  2011-07-18       Impact factor: 7.133

9.  ING2 (inhibitor of growth protein-2) plays a crucial role in preimplantation development.

Authors:  Lin Zhou; Pei Wang; Juanjuan Zhang; Boon Chin Heng; Guo Qing Tong
Journal:  Zygote       Date:  2015-02-12       Impact factor: 1.442

10.  Loss of Fam60a, a Sin3a subunit, results in embryonic lethality and is associated with aberrant methylation at a subset of gene promoters.

Authors:  Kenta Yashiro; Hidetaka Shiratori; Ryo Nabeshima; Osamu Nishimura; Takako Maeda; Natsumi Shimizu; Takahiro Ide; Yasuo Sakai; Chikara Meno; Mitsutaka Kadota; Shigehiro Kuraku; Hiroshi Hamada
Journal:  Elife       Date:  2018-08-02       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.